Patients & Caregivers
FDA Approves Diagnostic Test for Rare Blood Cancers
The FDA has approved Beckman Coulter's ClearLLab Reagents to help diagnose numerous rare blood cancers, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).
Pivotal Midostaurin Study in AML Patients Published in NEJM
The study observed that overall survival was significantly longer in the midostaurin group (74.7 months) compared to the placebo group (25.6 months; P = .009).
FDA Approves Subcutaneous Version of Rituximab For Several Rare Blood Cancers
The new route of administration can allow patients to be treated within minutes rather than the hours currently needed to administer rituximab intravenously.
Former Wilms' Tumor Patient Arrives at New York Jets Minicamp
Former hemihypertrophy and Wilms' tumor patient and current nose tackle Mike Pennel arrived at camp last week for his first week on the job as a New York Jet.
Lenvatinib Safe and Effective in Elderly Patients with Thyroid Cancer
There's a belief that these drugs should be withheld from elderly thyroid cancer patients due to toxicity and other medical concerns, but the results show lenvatinib is safe and effective.
Acceleron to Discontinue Development of Dalantercept for Kidney Cancer
Biotech company Accerelon announced it will discontinue development of dalantercept to treat RCC based on preliminary results from their DART Phase 2 study.
Multiple Myeloma Studies On Hold to Assess High Death Count
An increased number of deaths observed in 2 Phase 3 cancer studies involving Keytruda (pembrolizumab) in multiple myeloma patients has led Merck to pause recruitment.
The Battle Between Biosimilars and Neulasta
Monday was a good news and bad news day for Amgen and its drug, Neulasta (filgrastim).
60's Batman Adam West Loses Fight With Rare Cancer
Adam West has passed away after a brief battle with leukemia, a rare blood cancer. Leukemia refers to a group of cancers that originate in bone marrow.
Terminal Cancer Patient Arrested for Planning to Kill 3 Doctors
The note he left behind at his house read, "If today I do not kill them, their sins will continue."
<< Prev Page
Next Page >>
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.